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The conformational characteristics of three hexapeptides Boc-Leu-Xxx-Val-Leu-Aib-Val-OMe (Xxx = Ala 
1, D-Ala 2, Gly 3; Aib = a-aminoisobutyryl) have been probed in CDCl, solution by NMR methods using 
solvent perturbation of chemical shifts and radical broadening of NH resonances to delineate 
intramolecularly hydrogen bonded NH groups. Nuclear Overhauser effects (NOEs) provide additional 
information on preferred backbone conformations. The substituent at position 2 acts as a major 
conformational determinant. While a continuous 3 1, helical conformation is favoured for the peptide with 
Xxx = Ala, a multiple p-turns conformation is supported by both NMR and CD data for the peptide with 
Xxx = D-Ala. In the peptide with Xxx = Gly CD and NMR data suggest that both 3,, helical and multiple 
turns conformations are simultaneously populated. The results suggest that incorporation of D-amino 
acids and Aib residues into all L-sequences may prove useful in generating sequences containing multiple 
turns. 
The stereochemical features of P-turns,' widely occurring struc- 
tural elements in proteins, have been extensively in~estigated.~,~ 
P-Turns have also been the focus of recent interest as nucleating 
elements for P-hairpin formation."' P-Turns have been classi- 
fied into several types based on the conformational angles at the 
i + 1 and i + 2  residue^.^,^ Successive type 111 turns result in the 
generation of a 310 helical fold of the peptide chain. The occur- 
rence of consecutive p-turns of other types is much less frequent 
in proteins.' Multiple p-turn conformations can be generated 
when a single residue simultaneously occupies the i + 2 position 
of the first turn and the i + 1 position of the second turn. The 
recent observation of novel multiple p-turns in an antigenic 
segment of the HIV V 3 loop"' and the characterization of 
multiple turns in a short hydrophobic peptide containing both 
glycine and a-aminoisobutyryl (Aib) residues l3  prompted an 
attempt to design stable multiple turns in short synthetic pep- 
tides. The conformational characteristics of three acyclic hexa- 
peptides Boc-Leu-Xxx-Val-Leu-Aib-Val OMe (Xxx = ~ - A l a  1, 
D-Ala 2, Gly 3) are described in this report. 
The choice of the D-Ala residue at position 2 in peptide 2 was 
made with the intention of stabilizing a type I1 Leu-D-Ala p- 
turn, a feature expected in heterochiral sequences. 14~15 The 
choice of the Aib residue at position 5 was expected to stabilize 
the p-turn at the C terminus of the peptide. The presence of the 
D and L residues in short segments may be expected to destabil- 
ize continuous helix formation, a feature often observed in Aib 
containing peptides.'"'' 
Results and discussion 
NMR studies 
The solvent accessibility of NH groups in peptides 1-3 was 
probed using chemical shift perturbation in CDC1,-(CD,),SO l9 
mixtures and free radical (TEMPO) induced line broadening in 
CDCI3 solutions.20i2' Resonance assignments were carried out 
using a combination of COSY and NOESY/ROESY spectra.22 
Table 1 lists relevant chemical shift parameters. Figs. 1 and 2 
summarize the results of experiments designed to delineate the 
degree of solvent exposure of the peptide NH groups. Aggreg- 
t Fax: 91-80-3341683. E mail: pb@mbu.iisc.ernet.in 
ation effects are minimal as evidenced by the absence of any 
pronounced chemical shift changes over the concentration 
range 9.36 to 0.39 n i M  for peptide 2. 
Xxx = L-Ala 1. The Leu( 1) and Ala(2) NH groups are clearly 
solvent exposed as seen from the large effects in the solvent and 
radical perturbation experiments (Figs. 1, 2). The four remain- 
ing NH groups are inaccessible with Val(6) being the most sol- 
vent shielded. These observations are fully consistent with a 310- 
helical conformation [Fig. 3(u)] having four successive 4 --+ 1 
hydrogen bonds, involving the Va1(3), Leu(4), Aib(5) and Val(6) 
NH groups. This structure is also in accordance with a large 
body of data that suggests that even a single Aib residue in 
oligopeptides of length 6-7 residues promotes helix forma- 
tion." In NOE experiments the characteristic N,H-N, + , 
(dNN) connectivities were observed only between Leu( 1)- 
Ala(2) and Leu(4)+-+Aib(S) [Fig. 4(u)]. Limited chemical shift 
dispersion resulting in overlap of resonances and low NOE 
magnitudes are probably responsible for the non-observation of 
the continuous set of short d" connectivities. Several moderate 
to strong C,"H+-+N, + ,H NOEs are also observed [duN, Fig. 
4(a)]. In an ideal 3,,-helix the C,"H+-+N,+, distance is 3.4 8, 
while the NiH-N,+ ,H distance is 2 In short peptides 
NOEs are likely to be observed to distances of ca. 3.0-3.5 8, 
under the conditions used. The observation of strong duN NOEs 
characteristic of extendedhemi-extended residue conform- 
ations (ty ca. 120 ? 60") does suggest that multiple states may be 
populated, although the pattern of NH group accessibilities 
support a significant population of helical conformers. 
Xxx = D-Ala, 2. Peptide 2 differs dramatically from 1 in its 
NMR behaviour. The data in Fig. l(6) establish that Val(6) NH 
is strongly solvent shielded, while ~ -Ala (2 )  NH, Leu(4) NH 
and Aib(5) NH are moderately inaccessible. Val(3) NH is sur- 
prisingly accessible to solvent, showing the highest degree of 
solvent and radical induced perturbation [Fig. 2(b)]. In NOE 
experiments only a single dNN connectivity, Leu( l)-Ala(2) is 
observed. However, several d" NOEs [Fig. 4(6)] are observed 
characteristic of extendedhemi-extended conformations at 
individual residues. The NMR data are largely consistent with 
a major conformation shown in Fig. 3(6), which features a C, 
(y-turn) at Leu( l ) ,  a type 11' p-turn at the D-Ala-Val segment 
and a type I1 J3-turn at the Leu(4)-Aib(5) segment. The Aib(5) 
NH is exposed in this model, an inconsistency which may be 
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Table 1 NMR parameters" for peptides Boc-Leu-Xxx-Val-Leu-Aib-Val-OMe 
Chemical shifts S (ppm) 
Residue NH C"H CPH CYH C'H H/ H z 
Xxx Ala D-Ala Gly Ala D-Ala Gly Ala D-Ala Gly Ala D-Ala Gly Ala D-Ala Gly Ala D-Ala Gly 
Leu 5.08 5.76 5.41 3.95 4.08 4.03 1.5 1.61 1.52 1.61 1.60 1.60 0.90 0.94 0.94 5.4 6.6 5.5 
xxx 6.70 7.47 7.42 4.25 4.28 3.97 1.45 1.40 - - - - - - - 2.8 5.6 - 
Val 7.05 6.67 7.09 4.18 4.15 4.16 2.37 2.33 2.28 1.0 0.93 1.0 - - - 5.6 6.3 6.9 
Leu 7.17 7.24 7.11 4.39 4.33 4.38 1.69 1.69 1.68 1.69 1.69 1.72 0.94 0.93 0.94 7.5 7.4 7.9 
Aib 6.97 6.95 7.04 - - - 1.49 1.49 1.49 - - - - - - - - - 
Val 7.10 7.04 7.1 1 4.42 4.48 4.44 2.13 2.15 2.16 0.94 0.96 0.94 - - - 8.7 7.9 8.4 
~~~ ~ 
" Chemical shifts and coupling constants in CDCI,. 
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Fig. I Dependence of NH chemical shifts on the concentration of dimethyl sulfoxide (DMSO) (v/v) in CDCI, in peptides Boc-Leu-Xxx-Val- 
Leu-Aib-Val-OMe (1-3). Assignments are indicated using the one letter code (U = Aib). (a) Peptide 1 (Xxx = Ala), (b) peptide 2 (Xxx = D-Ala). 
(c) peptide 3 (Xxx = Gly). 
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Fig. 2 Changes in line width of NH resonances in peptides Boc-Leu-Xxx-Val-Leu-Aib-Val-OMe (1-3) with increasing concentration of TEMPO 
in CDC13 solution. (0 )  Peptide 1 (Xxx = Ala), (b) peptide 2 (Xxx = D-Ala), (c) peptide 3 (Xxx = Gly). 
rationalized by invoking a population of type I11 Leu(4)-Aib( 5 )  
p-turns, which in turn would result in a D-Ala CO* OHN-Leu ( 5 )  
4- 1 hydrogen bond. The large downfield shift of the 
Xxx(2) NH group in 2 as compared to 1 is consistent with its 
involvement in a 3 + 1 hydrogen bond in the D-Ala (2) pep- 
tide [Fig. 3(6)]. 
Interconversions between Type 11-111 p-turn conformations 
are readily possible by a flip of the central peptide unit, corres- 
ponding to a concerted rotation about the single bonds 
Cui+ ,-Ci+ ,O ( w i +  , )  and Ni+:-CUi+? ( q i + ? ) .  Indeed theor- 
etical calculations within an AM1 framework suggest an almost 
barrierless interconversion between type I1 and type I11 p-turns 
(L. Gomathi and J. Chandrasekhar, unpublished results). 
Xxx = Gly, 3. The Leu( I )  and Gly(2) NH groups are exposed 
to solvent, with the remaining four NH resonances being 
shielded [Figs. l(c) and 2(c)]. Successive d" and duN connectivi- 
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Table 2 
Xxx = Ala, D-Ala, Gly 
IR band position in Boc-Leu-Xxx-Val-Leu-Aib-Val-OMe; 
Fig. 3 Computer generated ball and stick structures for the peptide 
backbones. The idealized models were constructed using standard 
values of backbone dihedral angles. Structures were refined by energy 
minimization using the program INSIGHTII. Amino acid residues are 
indicated using the one letter code. Intramolecular hydrogen bonds are 
indicated by broken lines. (a) Peptide I (Xxx = L-Ala), (b) peptide 2 
(Xxx = D-Ala), (c) peptide 3 (Xxx = Gly). 
ties are also observed over the Leu( 1)-Aib(5) segment [Fig. 
4(c)]. The simultaneous observation of both types of inter- 
residue NOES is suggestive of a conformational equilibrium, 
although the NH solvent exposure data are broadly consistent 
with a major 3,,-helical conformation [Fig. 3(c)]. Interestingly, 
while peptide 3 resembles 1 in the pattern of NH accessibility, 
the low field position of the Gly(2) NH in 3 is similar to that 
observed in 2. 
Circular dichroism 
CD spectra of 1-3 are shown in Fig. 5.  Peptide 1 (Xxx = L-Ala) 
exhibits two negative bands at 223-225 and 203 nm, in both 
methanol and 2,2,2-trifluoroethanol (TFE), characteristic of 
small helical peptides [Fig. 5(a) and (b)]. Similar spectra with 
widely differing intensities of the n-x* and x-x * bands have been 
observed in earlier studies of short Aib containing helical 
sequences.23 The absence of solvent dependence is suggestive of 
a population of conformationally stable structures. Peptide 2 
(Xxx = D-Ala) has a dramatically different CD spectrum, with 
a negative band at ca. 230 nm and a positive band at 210 nm 
[Fig. 5(b)]. In this case also, the absence of pronounced sol- 
vent dependence suggests that conformer populations are not 
influenced by changing the solvent from methanol to TFE, a 
known helix promoter in helicogenic sequences.24 The positive 
band at 210 nm may be indicative of type I1 p-turn 
 conformation^,'^^^^^' while the long wavelength, 230 nm, band 
Ala D-Ala GlY 
3286.2 3323.0 3287.4 
3336.2 - 3330.1 
3418.3 3419.7 3426.2 
Ala D-Ala GlY 
1666.9 1668.9 1667.7 
1700.2 1732.7 1730.6 
has indeed been observed in small peptides earlier, and some- 
times ascribed to y-turns.2* 
Peptide 3 (Xxx = Gly) exhibits considerable variation in CD 
spectra on going from methanol to TFE [Fig. 5(c)]. In the for- 
mer, two negative bands are seen at 230 and 206 nm, while 
a weak positive band is observed at 215 nm. In the latter, only 
two negative bands are observed at 224 and 204 nm. Inspec- 
tion of the spectra for peptides 1-3 in Fig. 5 suggests that the 
observed CD spectra for the Gly peptide 3 may arise from con- 
tributions of the spectral types observed for peptides 1 and 2. 
Thus, in 3, conformational states characterized for both 1 and 2 
coexist, with populations varying appreciably with solvent. As 
already noted peptide 3 resembles 1 in the pattern of NH group 
accessibility [Fig. I(a)] but the Gly(2) NH chemical shift is 
anomalously low, a feature also seen in peptide 2. 
Infrared studies 
IR spectra were recorded for peptides 1-3 in dilute chloroform 
solutions (3 mM). The positions of the NH ( v N H )  and CO (vco) 
stretching bands are summarized in Table 2. Intense vNH bands 
in the region 3300-3340 cm-’ were observed in all cases, charac- 
teristics of intramolecularly hydrogen bonded conform- 
ations. In chloroform solution, the ratio of the intensity of the 
vNH (H bonded) to vNH (free) band follows the order 
L-AIa > Gly > D-Ala, confirming that the L-Ala peptide 1 has 
the largest population of intramolecularly hydrogen bonded 
species while the D-AI~  peptide 2 has the lowest. This conclu- 
sion is clearly consistent with NMR results. 
Conclusions 
Spectroscopic studies on the three acyclic hexapeptide Boc- 
Leu-Xxx(L-Ala, D-Ala, G1y)-Val-Leu-Aib-Val-OMe reveal that 
a single substitution at position 2 has a dramatic influence on 
the nature of the conformational distribution in solution. In a 
poorly solvating medium like CDCI, the NMR results support 
a major population of 310 helical conformations for peptide 1 
(Xxx = L-Ala). This conclusion is supported by the observed 
CD spectra which are similar to those frequently observed for 
short Aib containing peptides. NOE data for peptide 1 suggest 
that extended conformations are also populated, a feature 
which is consistent with the inherent flexibility in short 
sequences. NMR and CD results for peptide 2 (Xxx=~-Ala )  
strongly support a non-helical conformation with a y-turn 
favoured at Leu( l ) ,  a type 11‘ p-turn centred at the ~-Ala(2)- 
Val(3) segment and a type I1 p-turn at the Leu(4)-Aib(5) 
segment. The tendency of the Leu-Aib segment to adopt type 
I1 p-turns has been earlier established in both short and long 
peptide sequences in this l a b ~ r a t o r y . ~ ~ ~ ~ ~  The type 11’ p-turn for 
the D-Ala-Val segment is in accord with the known stability of 
such conformation in a heterochiral  sequence^.'^*'^ The spectro- 
scopic data for peptide 3 (Xxx = Gly) are clearly consistent with 
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Fig. 4 Partial ROESY spectra (400 MHz) of peptides 1,2,3 in CDCI,. Top panel shows C"H - NH NOEs and lower panel shows NH ++ NH 
NOEs. Assignments are marked on the 1 D spectra using the one letter code. Peptide concentration ca. 7-8 mM. (a)  Peptide 1 (Xxx = L-Ala). 
(b )  peptide 2 (Xxx = D-Ala), (c) peptide 3 (Xxx = Gly). 
a significantly greater degree of conformational flexibility. 
Analysis of CD and NMR results suggests that the 310 helical 
conformational state characterized for 1 and the multiple p-turn 
conformation suggested for 2 are simultaneously populated in 
the case of peptide 3. This conclusion is stereochemically rea- 
sonable since the Gly 2 reside can indeed adopt conformations 
accessible for both L - A ~  and D-Ala residues. The results of the 
present study demonstrate that folded multiple conformations 
can be appreciably populated in short acyclic sequences. Stabil- 
ization of a specific conformation may be achieved by appro- 
priate placement of o-Ala and Aib residues. Specific diagnostic 
spectral parameters may be used to establish conformational 
heterogeneity. The characterization of distinct conformational 
states in equilibrium may prove valuable in computer simula- 
tions which seek to explore the nature of conformational states 
accessible to short peptides. 
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CD spectra of peptides in MeOH (0) and TFE (a). Peptide concentration 1.43 x M for I ,  2 and 1.4 x lo-' M for 3. (ct)  Peptide 1 
Experiment a1 
Materials and methods 
The peptide was synthesized by conventional solution phase 
methods using a racemisation free fragment condensation 
strategy. The rerr-butoxycarbonyl (Boc) group was used for N- 
terminal protection and the C-terminal was protected as a 
methyl ester (OMe). Deprotection was achieved by 98%) formic 
acid or saponification, respectively. All intermediates were 
characterized by 'H NMR (80 MHz) and thin layer chroma- 
tography (TLC) on silica gel and used without further purifica- 
tion. The final peptides were purified by medium pressure liquid 
chromatography (MPLC) on a (40-60 p) column followed 
by HPLC purification on a CIS (10 p) column using methanol- 
water gradient elution. Peptide homogeneity was demonstrated 
by analytical HPLC (c18 5 p) and complete assignment of 400 
MHz 'H NMR spectra. 
All NMR studies were carried out on a Bruker AMX-400 
spectrometer. Resonance assignments were done using DFQ 
COSY and ROESY spectra." All 2D experiments were 
recorded in phase sensitive mode by using the time proportional 
phase incrementation. 1024 and 512 data points were used in t, 
and t ,  dimensions, respectively. The resultant data set was zero 
filled to finally yield 1K x 1K data points. A shifted square sine 
bell window was used in both dimensions. Spectral widths were 
in the region of 4500 Hz. Peptide concentration was 7-8 mM 
and the probe temperature was maintained at 298 K. C D  spec- 
tra were recorded on a JASCO 5-500 spectropolarimeter using 
a 1 mm path-length cell. 
Peptide synthesis 
Boc-Ala-Val-OMe (1). Boc Ala-OH ( 1.32 g, 6.98 mmol) was 
dissolved in 10 ml of dichloromethane (DCM) and cooled in an 
ice bath. H-Val-OMe, isolated from 2.33 g (13.96 mmol) of the 
hydrochloride by neutralization, subsequent extraction with 
ethyl acetate and concentration (5 ml), was added followed by 
1.43 g (6.98 mmol) of dicyclohexylcarbodiimide (DCC). The 
reaction mixture was allowed to warm to room temp. and 
stirred for 12 h. Dichloromethane was evaporated, the residue 
redissolved in ethyl acetate and dicyclohexylurea (DCU) was 
filtered off. The organic layer was washed with 1 M Na,CO, 
(3 x 30 ml), 1 M HCI (3 x 30 ml) and brine (3 x 30 ml), dried 
over anhydrous Na,SO, and evaporated to yield 2.42 g (96%) of 
white solid, which was directly used in further steps. 
Boc-Leu-Ala-Val-OMe (2). To 2.40 g (7.94 mmol) of 1, formic 
acid (18 ml) was added and the removal of the Boc group was 
monitored by TLC. After complete deprotection, the formic 
acid was removed in vocuo. The residue was taken in water (25 
ml) and washed with diethyl ether (2 x 30 ml). The pH of the 
aqueous solution was then adjusted to 8 with Na2C03 and 
extracted with EtOAc (4 x 30 ml). The EtOAc was dried over 
anhydrous Na,SO, and concentrated (5 ml). The dipeptide free 
base was added to an ice cold solution of Boc-Leu-OH (0.88 g, 
3.81 mmol) in 10 ml D M F  followed by DCC (0.784 g, 3.81 
mmol) and HOBT (2-hydroxybenzothiazole) (0.52 g, 3.8 1 
mmol) and stirred for 48 h. The reaction was worked up as 
described for 1. Yield 1.32 g (38%). 
Boc-Leu-Ala-Val-OH (3). 1.3 g (4.13 mmol) of 2 was dis- 
solved in methanol (40 ml) and 2 M NaOH (5 ml) was added. 
The mixture was stirred at room temp. and the progress of the 
reaction was followed by TLC. After complete saponification, 
methanol was evaporated. The reaction mixture was diluted 
with water and washed with diethyl ether (2 x 30 ml). The 
aqueous layer was acidified with 1 M HCl and extracted with 
EtOAc (3 x 30 ml). The combined ethyl acetate layer was dried 
over Na,SO, and evaporated to a solid which was used directly 
in further steps. Yield 1.2 g (92%). 
Boc D-Ala-Val-OMe (4). 1.89 g (10 mmol) of Boc-D-Ala-OH 
was dissolved in dichloromethane (1  5 ml) and cooled in an ice 
bath. H-Val-OMe, isolated from 3.35 g (20 mmol) of the 
hydrochloride was added, followed by DCC (2.06 g, 10 mmol). 
The reaction mixture was allowed to warm to room temp. and 
stirred for 24 h. Work up was as described for 1. Yield 2.5 g 
Boc-Leu-D-Ala-Val-OMe (5). Boc-Leu-OH (2.15 g, 9.3 
mmol) was coupled to the free dipeptide free base, isolated from 
4 (2.5 g 18.27 mmol) as described in the case of 2 in D M F  (10 
ml), using DCC (1.91 g, 9.3 mmol) and HOBT (1.26 g, 9.3 
mmol). The reaction mixture was stirred for 48 h. The reaction 
mixture was worked up as described for 2. Yield 1.75 g (45%). 
Boc-Leu-D-Ala-Val-OH (6). 1.70 g (5.09 mmol) of 5 was dis- 
solved in methanol (50 ml), 2 M NaOH (5 ml) was added and the 
solution was stirred at room temp. After complete saponific- 
ation, the mixture worked up as for 3. Yield 1.6 g (94%). 
Boc-Leu-Gly-OH (7). 2.25 g (6.85 mmol) of Boc-Leu-OSu 
(Su = succinimido) was dissolved in dry tetrahydrofuran (THF) 
(10 ml) and a solution of Gly-OH (0.6 g, 8 mmol) and triethyl- 
amine (0.98 ml) in H,O (10 ml) was added. After stirring at 
room temp. for 12 h, T H F  was evaporated. The aqueous solu- 
tion was acidified (pH cn. 2) with 1 M HCl and extracted with 
EtOAc (3 x 30 ml). The combined organic layer was dried over 
anhydrous Na,SO, and evaporated to give a white solid. Yield 
Boc-Leu-Gly-Val-OMe (8). Boc-Leu-Gly-OH (1.8 g, 6.33 
mmol) was cooled in ice and coupled to H-Val-OMe, isolated 
from 2.6 g (1  5 mmol) hydrochloride in D M F  using DCC ( 1.64 g, 
7.28 mmol) and HOBT (0.99 g, 7.28 mmol). The reaction mix- 
ture was allowed to warm to room temp. and stirred for 48 h. 
The reaction mixture was worked up as described for 2. Yield 
Boc-Leu-Gly-Val-OH (9). 2.0 g of 8 was dissolved in metha- 
(70%). 
1.85 g (84%). 
2.0 g (74%). 
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no1 (50 ml) and 2 M NaOH (5 ml) was added. The reaction 
mixture was stirred at room temp. After complete saponifica- 
tion, work up was as mentioned for 3. Yield 1.8 g (90%). 
Boc-Leu-Ala-Val-Leu-Aib-Val-OMe (10). To 0.98 g (2.28 
mmol) of B~c-Leu-Aib-Val-OMe,~~.~~ formic acid (9 ml) was 
added and removal of the Boc group was monitored by TLC. 
After complete deprotection, the formic acid was removed in 
vacuo. The residue was taken in water (10 ml) and washed with 
diethyl ether (2 x 20 ml). The pH of the aqueous layer was then 
adjusted to cn. 8 with Na,CO, and extracted with EtOAc 
(4 x 30 ml). The EtOAc extracts were pooled, dried over 
anhydrous Na2S0, and concentrated to about 5 ml; this sample 
was ninhydrin positive. This free tripeptide base was coupled to 
an ice-cooled solution of Boc-Leu-Ala-Val-OH (3) (1.18 g, 
2.94 mmol) in D M F  (10 ml) using DCC (0.6 g, 2.94 mmol) and 
HOBT (0.4 g, mmol). The reaction mixture was allowed to 
warm to room temp. and stirred for 4 d. After this period, 
EtOAc (15 ml) was added and the dicyclohexylurea (DCU) fil- 
tered off. The organic layer was washed with 2 M HCl (3 x 30 
ml), 1 M sodium carbonate (3 x 30 ml) and brine (3 x 30 ml), 
dried over anhydrous sodium sulfate and evaporated to yield 
1.49 g of white solid (76'M)). The final compound was purified 
and characterized 'H NMR (Table I ) .  Mp 175-178 "C. 
Boc-Leu-D-Ala-Val-Leu-Aib-Val-OMe (1 1). 1.5 g (3.5 mmol) 
of Boc-Leu-Aib-Val-OMe ** was dissolved in 98%) formic acid 
(12 ml). The removal of the Boc group was monitored by TLC. 
After complete deprotection, the tripeptide free base was 
coupled to Boc-Leu-D-Ala-Val-OH (6) (1.0 g, 2.4 mmol) in 
D M F  (10 ml) using DCC (0.494 g, 2.4 mmol) and HOBT (0.327 
g, 2.4 mmol). The mixture was stirred for 4 d, DCU filtered off 
and the product worked up as described in case of 10. Yield 
1.11 g (51%). The title compound was purified and character- 
ized by 'H NMR (Fable 1). M p  129-130 "C. 
Boc-Leu-Gly-Val-Leu-Aib-Val-OMe (12). 1.75 g (5.07 mmol) 
of Boc-Leu-Aib-Val-OMe was dissolved in 98% formic acid (1 5 
ml). The removal of the Boc group was monitored by TLC. The 
free base was isolated as described as in the case of 10 and was 
used without further purification. 2 g (5.15 mmol) of 9 was 
cooled in an ice bath and coupled with the tripeptide with free 
base in D M F  (10 ml) using DCC (1.06 g, 5.07 mmol) and 
HOBT (0.7 g, 5.07 mmol). The reaction mixture was stirred for 
4 d, DCU filtered off and the product worked up as described 
for 10 to yield 0.94 g (28%). The title peptide was purified and 
characterized by 'H NMR (Table 1). M p  125-130 "C. 
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